FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743291519> ?p ?o ?g. }

• W2743291519 endingPage "917" @default.
• W2743291519 startingPage "917" @default.
• W2743291519 abstract "Abstract Background: Follicular lymphoma (FL) is the most common subtype of indolent non Hodgkin's lymphoma (NHL). Median survival is long (>10 years), but current chemo-immunotherapy regimens used for FL are usually not curative. While T cells in the FL tumor microenvironment are considered dysfunctional and associated with disease progression, a better understanding of T-cell signaling may reveal how to productively engage tumor-infiltrating T cells to kill lymphoma B cells. Our previous study showed that expression of the immune checkpoint receptor PD-1 was directly correlated with reduced cytokine signaling in FL T cells (Myklebust et al., Blood 2013). Antibody immunotherapy targeting the PD-1/PD-L1 pathway has shown significant activity in solid tumors, but these benefits have not been as profound in NHLs, including FL. Co-blockade of checkpoint inhibitors may therefore be necessary to generate optimal anti-tumor responses in FL. The hypothesis underlying this study was that characterizing signaling responses in FL tumor-infiltrating T cells will identify new targets for combination of checkpoint blockade. Methods: Surface expression of 9 checkpoint receptors governing T cell function was measured in subsets of CD4 and CD8 T cells from FL lymph node tumors (n = 14) and from healthy donor tonsils (n= 11) and peripheral blood samples (n = 7) using fluorescence flow cytometry. Patterns of checkpoint receptor expression were compared with 1) intracellular phospho-protein signaling response and 2) cytokine production for subsets of T cells infiltrating FL tumors and the corresponding T-cell populations in healthy tonsils. Phospho-specific flow cytometry measured phosphorylation of STATs and T cell receptor (TCR) signaling effectors within minutes following stimulation by IL-4, IL-7, IL-21, or α-CD3+α-CD28 (TCR stimulation) antibodies. Results: CD4 and CD8 T cells infiltrating FL tumors were gated into subsets defined by PD-1 and ICOS protein expression, and compared to cognate T cell subsets in healthy tonsils. FL and tonsil T cells closely matched in their signaling responses to IL-4, IL-7, and IL-21 stimulation, with PD-1 expressing cells (CD4+PD-1hiICOS+ (TFH) and CD8+PD-1int T cells) exhibiting modest phospho-protein signaling responses compared to T cells not expressing PD-1. Furthermore, TCR membrane proximal signaling events (p-CD3ζ, p-SLP76) following TCR stimulation were comparable in FL and tonsil T cells. This contrasted reduced phospho-ERK signaling in all CD4 and CD8 T cell subsets infiltrating FL tumors which distinguished them from tonsillar T cells. IFN-γ production also differed between FL and tonsils, as CD8 T cells infiltrating FL tumors produced less IFN-γ. Reduced IFN-γ production was independent of PD-1 expression, suggesting suppressed function in these T cells which could be due to inhibitory receptors other than PD-1. Of the 9 checkpoint receptors measured, PD-1 and T cell Ig and ITIM domain (TIGIT) were expressed at the highest frequency. In FL, TIGIT was expressed in 58% and 80% of CD8 effector and effector memory cells, respectively, as compared to 43% and 68% of the cognate healthy tonsillar subsets. TIGIT was also frequently expressed in CD4 FL T cells, as 52% and 79% of effector and effector memory cells expressed TIGIT, respectively, as compared to 16% and 59% of the corresponding subsets from healthy tonsils. viSNE analysis demonstrated that TIGIT and PD-1 were frequently co-expressed in FL T cells, and a large fraction of PD-1int T cells had high expression of TIGIT (Figure 1). These results provide a rationale for co-blockade of PD-1 and TIGIT in FL and for investigation of how co-blockade impacts T cell functions. Conclusions: These results reveal specific suppression of cytokine signaling in CD8 effector T cells infiltrating FL tumors and identify TIGIT and PD-1 as strong candidates for co-checkpoint blockade in FL. A deeper understanding of the interplay between checkpoint receptors and key T cell cytokine signaling events in FL will further assist in engineering immuno-therapeutic regiments that improve FL patient clinical outcomes. Disclosures Kolstad: Nordic Nanovector: Other: Membership of Scientific Advisory Board. Levy:Kite Pharma: Consultancy; Five Prime Therapeutics: Consultancy; Innate Pharma: Consultancy; Beigene: Consultancy; Corvus: Consultancy; Dynavax: Research Funding; Pharmacyclics: Research Funding. Irish:Incyte: Research Funding; Janssen: Research Funding; Cytobank, Inc.: Equity Ownership, Membership on an entity's Board of Directors or advisory committees." @default.
• W2743291519 created "2017-08-17" @default.
• W2743291519 creator A5004859097 @default.
• W2743291519 creator A5007823953 @default.
• W2743291519 creator A5034885528 @default.
• W2743291519 creator A5040680720 @default.
• W2743291519 creator A5060357925 @default.
• W2743291519 creator A5074920774 @default.
• W2743291519 creator A5077678938 @default.
• W2743291519 creator A5083342021 @default.
• W2743291519 creator A5090605318 @default.
• W2743291519 date "2016-12-02" @default.
• W2743291519 modified "2023-10-18" @default.
• W2743291519 title "Identification of Tigit on Intra-Tumor T Cells As a New Target for Immune Checkpoint Blockade in Follicular Lymphoma" @default.
• W2743291519 doi "https://doi.org/10.1182/blood.v128.22.917.917" @default.
• W2743291519 hasPublicationYear "2016" @default.
• W2743291519 type Work @default.
• W2743291519 sameAs 2743291519 @default.
• W2743291519 citedByCount "1" @default.
• W2743291519 countsByYear W27432915192020 @default.
• W2743291519 crossrefType "journal-article" @default.
• W2743291519 hasAuthorship W2743291519A5004859097 @default.
• W2743291519 hasAuthorship W2743291519A5007823953 @default.
• W2743291519 hasAuthorship W2743291519A5034885528 @default.
• W2743291519 hasAuthorship W2743291519A5040680720 @default.
• W2743291519 hasAuthorship W2743291519A5060357925 @default.
• W2743291519 hasAuthorship W2743291519A5074920774 @default.
• W2743291519 hasAuthorship W2743291519A5077678938 @default.
• W2743291519 hasAuthorship W2743291519A5083342021 @default.
• W2743291519 hasAuthorship W2743291519A5090605318 @default.
• W2743291519 hasConcept C167672396 @default.
• W2743291519 hasConcept C203014093 @default.
• W2743291519 hasConcept C2776090121 @default.
• W2743291519 hasConcept C2776107976 @default.
• W2743291519 hasConcept C2777058707 @default.
• W2743291519 hasConcept C2777701055 @default.
• W2743291519 hasConcept C2778690821 @default.
• W2743291519 hasConcept C2779118045 @default.
• W2743291519 hasConcept C2779338263 @default.
• W2743291519 hasConcept C2780851360 @default.
• W2743291519 hasConcept C502942594 @default.
• W2743291519 hasConcept C71924100 @default.
• W2743291519 hasConcept C86803240 @default.
• W2743291519 hasConcept C8891405 @default.
• W2743291519 hasConceptScore W2743291519C167672396 @default.
• W2743291519 hasConceptScore W2743291519C203014093 @default.
• W2743291519 hasConceptScore W2743291519C2776090121 @default.
• W2743291519 hasConceptScore W2743291519C2776107976 @default.
• W2743291519 hasConceptScore W2743291519C2777058707 @default.
• W2743291519 hasConceptScore W2743291519C2777701055 @default.
• W2743291519 hasConceptScore W2743291519C2778690821 @default.
• W2743291519 hasConceptScore W2743291519C2779118045 @default.
• W2743291519 hasConceptScore W2743291519C2779338263 @default.
• W2743291519 hasConceptScore W2743291519C2780851360 @default.
• W2743291519 hasConceptScore W2743291519C502942594 @default.
• W2743291519 hasConceptScore W2743291519C71924100 @default.
• W2743291519 hasConceptScore W2743291519C86803240 @default.
• W2743291519 hasConceptScore W2743291519C8891405 @default.
• W2743291519 hasIssue "22" @default.
• W2743291519 hasLocation W27432915191 @default.
• W2743291519 hasOpenAccess W2743291519 @default.
• W2743291519 hasPrimaryLocation W27432915191 @default.
• W2743291519 hasRelatedWork W2563663251 @default.
• W2743291519 hasRelatedWork W3034810867 @default.
• W2743291519 hasRelatedWork W3197243161 @default.
• W2743291519 hasRelatedWork W3197924926 @default.
• W2743291519 hasRelatedWork W3204309362 @default.
• W2743291519 hasRelatedWork W3217412908 @default.
• W2743291519 hasRelatedWork W4224222365 @default.
• W2743291519 hasRelatedWork W4281389645 @default.
• W2743291519 hasRelatedWork W4323827654 @default.
• W2743291519 hasRelatedWork W4366590730 @default.
• W2743291519 hasVolume "128" @default.
• W2743291519 isParatext "false" @default.
• W2743291519 isRetracted "false" @default.
• W2743291519 magId "2743291519" @default.
• W2743291519 workType "article" @default.